TrialOrphanet journal of rare diseases2021

D-galactose supplementation in individuals with PMM2-CDG: results of a multicenter, open label, prospective pilot clinical trial.

Peter Witters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.